Congress Wants To Show Voters They’re Serious About Healthcare? Fix Medicare Part D
We’re nearly 50 days out from the 2018 midterm elections. While there are many (MANY) unknowns that will undoubtedly affect...
We’re nearly 50 days out from the 2018 midterm elections. While there are many (MANY) unknowns that will undoubtedly affect...
This week, multiple associations and hospital groups refiled a lawsuit to reverse changes made to the 340B program. We’ve written...
For most people, a trip to the hospital is frightening. Even for routine treatments, hospitalizations can be confusing and anxiety...
Recently, Democrats have reinvigorated calls for a single payer healthcare system, popularized in Senator Bernie Sanders’ “Medicare for all” plan....
2018 has been a watershed year for the effort to reform our nation’s healthcare system and bring down the cost...
Last week, U.S. Department of Health and Human Services Secretary Alex Azar spoke at The Heritage Foundation about the importance...
Sen. Richard Durbin (D-IL) introduced an amendment to an appropriations bill this week that would force drug manufacturers to disclose...
Last week, U.S. Health and Human Services (HHS) Secretary Alex Azar testified before Congress on the 340B program, an almost...
Matthew Kandrach – President, CASE July 12, 2018 – https://washex.am/2ufXYBS With summer upon us and the midterm elections looming large, Congress...
In last week’s Senate Finance Committee hearing on drug pricing, U.S. Secretary of Health and Human Services Alex Azar reiterated the Trump...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2025 · Case for Consumers